Correction to: The Mitochondria-Targeted Methylglyoxal Sequestering Compound, MitoGamide, Is Cardioprotective in the Diabetic Heart (Cardiovascular Drugs and Therapy, (2019), 33, 6, (669-674), 10.1007/s10557-019-06914-9)

Mitchel Tate; Gavin C. Higgins; Miles J. De Blasio; Runa Lindblom; Darnel Prakoso; Minh Deo; Helen Kiriazis; Min Park; Carlos D. Baeza-Garza; Stuart T. Caldwell; Richard C. Hartley; Thomas Krieg; Michael P. Murphy; Melinda T. Coughlan; Rebecca H. Ritchie

doi:10.1007/s10557-019-06929-2

Correction to: The Mitochondria-Targeted Methylglyoxal Sequestering Compound, MitoGamide, Is Cardioprotective in the Diabetic Heart (Cardiovascular Drugs and Therapy, (2019), 33, 6, (669-674), 10.1007/s10557-019-06914-9)

Mitchel Tate, Gavin C. Higgins, Miles J. De Blasio, Runa Lindblom, Darnel Prakoso, Minh Deo, Helen Kiriazis, Min Park, Carlos D. Baeza-Garza, Stuart T. Caldwell, Richard C. Hartley, Thomas Krieg, Michael P. Murphy, Melinda T. Coughlan, Rebecca H. Ritchie

Diabetes

Research output: Contribution to journal › Comment / Debate › Other › peer-review

3 Citations (Scopus)

Abstract

The article “The Mitochondria-Targeted Methylglyoxal Sequestering Compound, MitoGamide, Is Cardioprotective in the Diabetic Heart” written by Mitchel Tate, Gavin C. Higgins, Miles J. De Blasio, Runa Lindblom, Darnel Prakoso, Minh Deo, Helen Kiriazis, Min Park, Carlos D. Baeza-Garza, Stuart T. Caldwell, Richard C. Hartley, Thomas Krieg, Michael P. Murphy, Melinda T. Coughlan, and Rebecca H. Ritchie was originally published Online First without Open Access. After publication, the author decided to opt for Open Choice and to make the article an Open Access publication. Therefore, the copyright of the article has been changed to © The Author(s) 2019 and the article is forthwith distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits use, duplication, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The original article has been corrected.

Original language	English
Pages (from-to)	223
Number of pages	1
Journal	Cardiovascular Drugs and Therapy
Volume	34
Issue number	2
DOIs	https://doi.org/10.1007/s10557-019-06929-2
Publication status	Published - 1 Apr 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s10557-019-06929-2

Cite this

Tate, M., Higgins, G. C., De Blasio, M. J., Lindblom, R., Prakoso, D., Deo, M., Kiriazis, H., Park, M., Baeza-Garza, C. D., Caldwell, S. T., Hartley, R. C., Krieg, T., Murphy, M. P., Coughlan, M. T., & Ritchie, R. H. (2020). Correction to: The Mitochondria-Targeted Methylglyoxal Sequestering Compound, MitoGamide, Is Cardioprotective in the Diabetic Heart (Cardiovascular Drugs and Therapy, (2019), 33, 6, (669-674), 10.1007/s10557-019-06914-9). Cardiovascular Drugs and Therapy, 34(2), 223. https://doi.org/10.1007/s10557-019-06929-2

@article{57084fd935a94b40aa1bb5a707ab1cb0,

title = "Correction to: The Mitochondria-Targeted Methylglyoxal Sequestering Compound, MitoGamide, Is Cardioprotective in the Diabetic Heart (Cardiovascular Drugs and Therapy, (2019), 33, 6, (669-674), 10.1007/s10557-019-06914-9)",

abstract = "The article “The Mitochondria-Targeted Methylglyoxal Sequestering Compound, MitoGamide, Is Cardioprotective in the Diabetic Heart” written by Mitchel Tate, Gavin C. Higgins, Miles J. De Blasio, Runa Lindblom, Darnel Prakoso, Minh Deo, Helen Kiriazis, Min Park, Carlos D. Baeza-Garza, Stuart T. Caldwell, Richard C. Hartley, Thomas Krieg, Michael P. Murphy, Melinda T. Coughlan, and Rebecca H. Ritchie was originally published Online First without Open Access. After publication, the author decided to opt for Open Choice and to make the article an Open Access publication. Therefore, the copyright of the article has been changed to {\textcopyright} The Author(s) 2019 and the article is forthwith distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits use, duplication, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The original article has been corrected. ",

author = "Mitchel Tate and Higgins, {Gavin C.} and {De Blasio}, {Miles J.} and Runa Lindblom and Darnel Prakoso and Minh Deo and Helen Kiriazis and Min Park and Baeza-Garza, {Carlos D.} and Caldwell, {Stuart T.} and Hartley, {Richard C.} and Thomas Krieg and Murphy, {Michael P.} and Coughlan, {Melinda T.} and Ritchie, {Rebecca H.}",

year = "2020",

month = apr,

day = "1",

doi = "10.1007/s10557-019-06929-2",

language = "English",

volume = "34",

pages = "223",

journal = "Cardiovascular Drugs and Therapy",

issn = "0920-3206",

publisher = "Springer",

number = "2",

}

Tate, M, Higgins, GC, De Blasio, MJ, Lindblom, R, Prakoso, D, Deo, M, Kiriazis, H, Park, M, Baeza-Garza, CD, Caldwell, ST, Hartley, RC, Krieg, T, Murphy, MP, Coughlan, MT & Ritchie, RH 2020, 'Correction to: The Mitochondria-Targeted Methylglyoxal Sequestering Compound, MitoGamide, Is Cardioprotective in the Diabetic Heart (Cardiovascular Drugs and Therapy, (2019), 33, 6, (669-674), 10.1007/s10557-019-06914-9)', Cardiovascular Drugs and Therapy, vol. 34, no. 2, pp. 223. https://doi.org/10.1007/s10557-019-06929-2

Correction to: The Mitochondria-Targeted Methylglyoxal Sequestering Compound, MitoGamide, Is Cardioprotective in the Diabetic Heart (Cardiovascular Drugs and Therapy, (2019), 33, 6, (669-674), 10.1007/s10557-019-06914-9). / Tate, Mitchel; Higgins, Gavin C.; De Blasio, Miles J. et al.
In: Cardiovascular Drugs and Therapy, Vol. 34, No. 2, 01.04.2020, p. 223.

Research output: Contribution to journal › Comment / Debate › Other › peer-review

TY - JOUR

T1 - Correction to

T2 - The Mitochondria-Targeted Methylglyoxal Sequestering Compound, MitoGamide, Is Cardioprotective in the Diabetic Heart (Cardiovascular Drugs and Therapy, (2019), 33, 6, (669-674), 10.1007/s10557-019-06914-9)

AU - Tate, Mitchel

AU - Higgins, Gavin C.

AU - De Blasio, Miles J.

AU - Lindblom, Runa

AU - Prakoso, Darnel

AU - Deo, Minh

AU - Kiriazis, Helen

AU - Park, Min

AU - Baeza-Garza, Carlos D.

AU - Caldwell, Stuart T.

AU - Hartley, Richard C.

AU - Krieg, Thomas

AU - Murphy, Michael P.

AU - Coughlan, Melinda T.

AU - Ritchie, Rebecca H.

PY - 2020/4/1

Y1 - 2020/4/1

N2 - The article “The Mitochondria-Targeted Methylglyoxal Sequestering Compound, MitoGamide, Is Cardioprotective in the Diabetic Heart” written by Mitchel Tate, Gavin C. Higgins, Miles J. De Blasio, Runa Lindblom, Darnel Prakoso, Minh Deo, Helen Kiriazis, Min Park, Carlos D. Baeza-Garza, Stuart T. Caldwell, Richard C. Hartley, Thomas Krieg, Michael P. Murphy, Melinda T. Coughlan, and Rebecca H. Ritchie was originally published Online First without Open Access. After publication, the author decided to opt for Open Choice and to make the article an Open Access publication. Therefore, the copyright of the article has been changed to © The Author(s) 2019 and the article is forthwith distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits use, duplication, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The original article has been corrected.

AB - The article “The Mitochondria-Targeted Methylglyoxal Sequestering Compound, MitoGamide, Is Cardioprotective in the Diabetic Heart” written by Mitchel Tate, Gavin C. Higgins, Miles J. De Blasio, Runa Lindblom, Darnel Prakoso, Minh Deo, Helen Kiriazis, Min Park, Carlos D. Baeza-Garza, Stuart T. Caldwell, Richard C. Hartley, Thomas Krieg, Michael P. Murphy, Melinda T. Coughlan, and Rebecca H. Ritchie was originally published Online First without Open Access. After publication, the author decided to opt for Open Choice and to make the article an Open Access publication. Therefore, the copyright of the article has been changed to © The Author(s) 2019 and the article is forthwith distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits use, duplication, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The original article has been corrected.

UR - http://www.scopus.com/inward/record.url?scp=85079715301&partnerID=8YFLogxK

U2 - 10.1007/s10557-019-06929-2

DO - 10.1007/s10557-019-06929-2

M3 - Comment / Debate

C2 - 32062792

AN - SCOPUS:85079715301

SN - 0920-3206

VL - 34

SP - 223

JO - Cardiovascular Drugs and Therapy

JF - Cardiovascular Drugs and Therapy

IS - 2

ER -

Tate M, Higgins GC, De Blasio MJ, Lindblom R, Prakoso D, Deo M et al. Correction to: The Mitochondria-Targeted Methylglyoxal Sequestering Compound, MitoGamide, Is Cardioprotective in the Diabetic Heart (Cardiovascular Drugs and Therapy, (2019), 33, 6, (669-674), 10.1007/s10557-019-06914-9). Cardiovascular Drugs and Therapy. 2020 Apr 1;34(2):223. doi: 10.1007/s10557-019-06929-2

Correction to: The Mitochondria-Targeted Methylglyoxal Sequestering Compound, MitoGamide, Is Cardioprotective in the Diabetic Heart (Cardiovascular Drugs and Therapy, (2019), 33, 6, (669-674), 10.1007/s10557-019-06914-9)

Abstract

UN SDGs

Access to Document

Other files and links

Research output

The Mitochondria-Targeted Methylglyoxal Sequestering Compound, MitoGamide, Is Cardioprotective in the Diabetic Heart

Cite this